News - Page 648

AstroTalk, an Indian spiritual tech startup, has raised $20 million in a Series A funding round led by New York-based venture capital firm Left Lane Capital. The funds will be used for

Bupa, the health insurance company, has launched a $20 million venture capital (VC) fund to invest in Australian healthcare startups. Bupa Ventures will focus on early-stage investments, from seed funding to Series

TLDR: – Sea Machines, a global leader in autonomous piloting systems for sea vessels, has secured a $12 million investment from cleantech venture capital firm Emerald Technology Ventures. – The investment will

African tech startup funding saw a significant decline in 2023, breaking a trend of growth since 2017. According to the African Tech Startups Funding Report, a total of 406 startups raised a

TLDR: The crypto venture capital landscape experienced a significant increase in investment projects in January 2024. There were 113 publicly disclosed investment projects, which is a 10.8% increase compared to December 2023.

TLDR: – Blackbird Ventures, the venture capital firm behind the Kiki debacle, has faced criticism from women-led startups for its lack of support for female founders. – Women founders argue that Blackbird

TLDR: AP Innovation Society (APIS) and DeepTech Naipunya Foundation (DTNF) have signed a memorandum of understanding (MoU) to promote innovation culture in Andhra Pradesh. The MoU aims to create new business ventures

Arcanum Capital is utilizing tokenization to democratize access to traditional venture capital investments. By converting fund shares into digital tokens, the firm aims to make venture capital more accessible and inclusive. Tokenization,

TLDR: Arcanum Capital is a venture capital firm that bridges the worlds of professional sports and blockchain venture capitalism. The co-founders, James McDowall and Luchang Zheng, discussed their journeys and the success

Medicxi, a London-based venture capital firm, is merging six dermatology biotechs into one entity called Alys Pharmaceuticals. The combined company will have a multi-platform pipeline focused on immuno-dermatology, with a dozen active